Literature DB >> 15820315

A nonimprinted Prader-Willi Syndrome (PWS)-region gene regulates a different chromosomal domain in trans but the imprinted pws loci do not alter genome-wide mRNA levels.

Mihaela Stefan1, Toni Portis, Richard Longnecker, Robert D Nicholls.   

Abstract

Prader-Willi syndrome (PWS) is a complex neurobehavioral disorder that results from loss of function of 10 clustered, paternally expressed genes in a 1.5-Mb region of chromosome 15q11-q13. Many of the primary PWS region genes appear to have nuclear RNA regulatory functions, suggesting that multiple genetic pathways could be secondarily affected in PWS. Using a transgenic mouse model of PWS (TgPWS) with an approximately 4-Mb chromosome 7C deletion of paternal origin that models the neonatal phenotype of the human syndrome we compared by oligonucleotide microarrays expression levels of approximately 12,000 genes and ESTs in TgPWS and wild-type brain. Hybridization data were processed with two distinct statistical algorithms and revealed a dramatically reduced expression of 4 imprinted genes within the deletion region in TgPWS mice, with 2 nonimprinted, codeleted genes reduced twofold. However, only 3 genes outside the deletion were significantly altered in TgPWS mouse brain, with approximately 1.5-fold up-regulation of mRNA levels. Remarkably, these genes map to a single chromosome domain (18B3), and by quantitative RT-PCR we show that 8 genes in this domain are up-regulated in TgPWS brain. These 18B3 genes were up-regulated in an equivalent manner in Angelman syndrome mouse (TgAS) brain, which has the same deletion but of maternal origin. Therefore, the trans-regulation of the chromosome 18B3 domain is due to decreased expression of a nonimprinted gene within the TgPWS/AS mouse deletion in mouse chromosome 7C. Most surprisingly, since 48-60% of the genome was screened, it appears that the imprinted mouse PWS loci do not widely regulate mRNA levels of other genes and may regulate RNA structure.

Entities:  

Mesh:

Year:  2005        PMID: 15820315     DOI: 10.1016/j.ygeno.2005.02.004

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  Global deficits in development, function, and gene expression in the endocrine pancreas in a deletion mouse model of Prader-Willi syndrome.

Authors:  Mihaela Stefan; Rebecca A Simmons; Suzanne Bertera; Massimo Trucco; Farzad Esni; Peter Drain; Robert D Nicholls
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-02-22       Impact factor: 4.310

Review 2.  Cognitive deficits in the Snord116 deletion mouse model for Prader-Willi syndrome.

Authors:  Anna Adhikari; Nycole A Copping; Beth Onaga; Michael C Pride; Rochelle L Coulson; Mu Yang; Dag H Yasui; Janine M LaSalle; Jill L Silverman
Journal:  Neurobiol Learn Mem       Date:  2018-05-23       Impact factor: 2.877

3.  Whole genome microarray analysis of gene expression in an imprinting center deletion mouse model of Prader-Willi syndrome.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Steven G McNulty; Daniel J Driscoll; Merlin G Butler; Robert A White
Journal:  Am J Med Genet A       Date:  2007-03-01       Impact factor: 2.802

4.  15q11.2-13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain.

Authors:  Dag H Yasui; Haley A Scoles; Shin-Ichi Horike; Makiko Meguro-Horike; Keith W Dunaway; Diane I Schroeder; Janine M Lasalle
Journal:  Hum Mol Genet       Date:  2011-08-12       Impact factor: 6.150

5.  Whole genome microarray analysis of gene expression in Prader-Willi syndrome.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Susan M Sell; Theresa V Strong; Merlin G Butler
Journal:  Am J Med Genet A       Date:  2007-03-01       Impact factor: 2.802

6.  Neonatal maternal deprivation response and developmental changes in gene expression revealed by hypothalamic gene expression profiling in mice.

Authors:  Feng Ding; Hong Hua Li; Jun Li; Richard M Myers; Uta Francke
Journal:  PLoS One       Date:  2010-02-24       Impact factor: 3.240

7.  Recommendations for the investigation of animal models of Prader-Willi syndrome.

Authors:  James L Resnick; Robert D Nicholls; Rachel Wevrick
Journal:  Mamm Genome       Date:  2013-04-23       Impact factor: 2.957

8.  Whole genome microarray analysis of gene expression in subjects with fragile X syndrome.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Merlin G Butler
Journal:  Genet Med       Date:  2007-07       Impact factor: 8.822

9.  A UPF3-mediated regulatory switch that maintains RNA surveillance.

Authors:  Wai-Kin Chan; Angela D Bhalla; Hervé Le Hir; Lam Son Nguyen; Lulu Huang; Jozef Gécz; Miles F Wilkinson
Journal:  Nat Struct Mol Biol       Date:  2009-06-07       Impact factor: 15.369

10.  Transcriptional and post-transcriptional regulation of SPAST, the gene most frequently mutated in hereditary spastic paraplegia.

Authors:  Brian J Henson; Wan Zhu; Kelsey Hardaway; Jaime L Wetzel; Mihaela Stefan; Kathryn M Albers; Robert D Nicholls
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.